Sapir Alex — SEC Form 4 filings

SEC reporting owner CIK 1709415. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-05 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Fulcrum Therapeutics, Inc. (FULC)See Remarks, Director41 leg · 43,360 sh · $492,0284

Form 4 filings — Sapir Alex

FiledFormIssuerReported transactionsSource
2026-02-044Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 650,000 (derivative) @ $0EDGAR
2025-01-284Fulcrum Therapeutics, Inc. (FULC)Grant/award (A): 582,000 (derivative) @ $0EDGAR
2024-07-084Fulcrum Therapeutics, Inc. (FULC)Option exercise (M): 150,000 @ $3.27 · Option exercise (M): 150,000 (derivative) @ $0EDGAR
2024-03-054Fulcrum Therapeutics, Inc. (FULC)Purchase (P): 43,360 @ $11.35EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709415 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →